1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bacterial Infections, Gram-Negative

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Bacterial Infections, Gram-Negative in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	7 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dhainaut, JF; Dreyfuss, D; Holzapfel, L; Le Tulzo, Y; Mira, JP; Schlemmer, B; Solet, JP; Tenaillon, A; Wolff, M; Zeni, F	1
Eling, WM; Hermsen, CC; Huys, HL; van der Meer, JW; Vogels, MT	1
Frasa, H; Hoepelman, AI; Hustinx, WM; Verhoef, J	1
Abdullah, F; Mathiak, G; Ovadia, P; Rabinovici, R; Szewczyk, D	1
Damas, P; de Vathaire, F; Dhainaut, JF; Gourlay, ML; Guinot, P; Hemmer, M; Holzapfel, L; Le Tulzo, Y; Mira, JP; Radermacher, P; Schaller, MD; Sollet, JP; Tenaillon, A; Vedrinne, JM; Wolff, M; Zeni, F	1
Quinn, JV; Slotman, GJ	1
Carroll, ML; DeJoy, SQ; Kerwar, SS; Kohler, CA; Oronsky, AL; Pickett, WC; Schaub, RE; Torley, LW; Wissner, A	1

Reviews

2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bacterial Infections, Gram-Negative

Article	Year
Issues in the adjunct therapy of severe sepsis. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:2 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cytokines; Endotoxins; Gram-Negative Bacterial Infections; Humans; Interleukin-6; Nitric Oxide; Platelet Activating Factor; Receptors, Interleukin-1; Shock, Septic; Tumor Necrosis Factor-alpha	1996
Platelet-activating factor (PAF) in experimental and clinical sepsis. Shock (Augusta, Ga.), 1997, Volume: 7, Issue:6 Topics: Animals; Gram-Negative Bacterial Infections; Humans; Platelet Activating Factor; Sepsis	1997

Trials

2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bacterial Infections, Gram-Negative

Article	Year
Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Critical care medicine, 1994, Volume: 22, Issue:11 Topics: Adult; Aged; APACHE; Diterpenes; Double-Blind Method; France; Ginkgolides; Gram-Negative Bacterial Infections; Humans; Lactones; Middle Aged; Placebos; Platelet Activating Factor; Prognosis; Statistics as Topic; Systemic Inflammatory Response Syndrome	1994
Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. Critical care medicine, 1998, Volume: 26, Issue:12 Topics: Adult; Aged; Analysis of Variance; APACHE; Diterpenes; Double-Blind Method; Free Radical Scavengers; Ginkgolides; Gram-Negative Bacterial Infections; Humans; Lactones; Middle Aged; Platelet Activating Factor; Prospective Studies; Sepsis; Survival Analysis	1998

Article

Year

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.

Critical care medicine, 1994, Volume: 22, Issue:11

Topics: Adult; Aged; APACHE; Diterpenes; Double-Blind Method; France; Ginkgolides; Gram-Negative Bacterial Infections; Humans; Lactones; Middle Aged; Placebos; Platelet Activating Factor; Prognosis; Statistics as Topic; Systemic Inflammatory Response Syndrome

1994

Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group.

Critical care medicine, 1998, Volume: 26, Issue:12

Topics: Adult; Aged; Analysis of Variance; APACHE; Diterpenes; Double-Blind Method; Free Radical Scavengers; Ginkgolides; Gram-Negative Bacterial Infections; Humans; Lactones; Middle Aged; Platelet Activating Factor; Prospective Studies; Sepsis; Survival Analysis

1998

Other Studies

3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bacterial Infections, Gram-Negative

Article	Year
Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice. Infection and immunity, 1994, Volume: 62, Issue:5 Topics: Animals; Arachidonic Acid; Female; Gram-Negative Bacterial Infections; Granulocyte-Macrophage Colony-Stimulating Factor; Immunoglobulin G; Interleukin-1; Mice; Neutropenia; Platelet Activating Factor; Tumor Necrosis Factor-alpha	1994
Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock. Critical care medicine, 1999, Volume: 27, Issue:11 Topics: Aeromonas hydrophila; Animals; Arachidonic Acid; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Eicosanoids; Female; Gram-Negative Bacterial Infections; Heart Diseases; Hemodynamics; Hypertension, Pulmonary; Lipoxygenase Inhibitors; Masoprocol; Oxazoles; Oxygen; Oxygen Consumption; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Shock, Septic; Swine; Thromboxane A2; Triazoles; Tumor Necrosis Factor-alpha	1999
Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsis. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:9 Topics: Animals; Blood Pressure; Female; Gram-Negative Bacterial Infections; Humans; Hypotension; Interleukin-6; Macaca fascicularis; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Organophosphorus Compounds; Permeability; Platelet Activating Factor; Rabbits; Rats; Rats, Wistar; Thiazoles; Tumor Necrosis Factor-alpha	1992